have identified the advantages and disadvantages of major biomarkers of GBM, such as O6-methylguanine-DNA methyltransferase, epidermal growth factor receptor, platelet-derived growth factor alpha receptor, and isocitrate dehydrogenase (5). The gene discussed is MGMT; the disease is glioblastoma.